MODERATE-TO-SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE-TO-SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for eczema shows promise in large trial
Disease control OngoingThis study tests an experimental drug called SHR-1819 for people with moderate to severe atopic dermatitis (eczema). About 652 adults will receive either the drug or a placebo to see if it improves skin symptoms and reduces itching. The main goal is to measure skin clearing and i…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests a new drug called rezpegaldesleukin for adults with moderate-to-severe eczema (atopic dermatitis). About 396 participants will receive either the drug or a placebo for 16 weeks, and those who improve may continue treatment for up to a year. The goal is to see if …
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC